Rallybio Corporation (RLYB) Misses Q4 EPS by 3c

March 12, 2024 8:01 AM EDT

Rallybio Corporation (NASDAQ: RLYB) reported Q4 EPS of ($0.50), $0.03 worse than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Rallybio Corporation (RLYB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings